J. Goldman & Co LP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 140 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$32,226
-16.3%
29,8390.0%0.00%0.0%
Q2 2023$38,492
-2.3%
29,8390.0%0.00%
-50.0%
Q1 2023$39,387
-12.0%
29,8390.0%0.00%0.0%
Q4 2022$44,759
+27.9%
29,8390.0%0.00%0.0%
Q3 2022$35,000
-81.2%
29,839
-81.9%
0.00%
-77.8%
Q2 2022$186,000
-88.3%
164,839
-68.9%
0.01%
-87.5%
Q1 2022$1,584,000
+211.8%
529,905
+176.2%
0.07%
+157.1%
Q4 2021$508,000
+99.2%
191,839
+172.7%
0.03%
+115.4%
Q3 2021$255,000
-81.5%
70,339
-77.9%
0.01%
-75.9%
Q2 2021$1,382,000
+737.6%
318,456
+560.3%
0.05%
+980.0%
Q1 2021$165,000
-83.9%
48,229
-83.5%
0.01%
-90.4%
Q4 2020$1,026,000
-49.3%
293,039
-65.2%
0.05%
-62.0%
Q3 2020$2,022,000
+7.6%
842,486
-18.0%
0.14%
+18.1%
Q2 2020$1,879,000
+311.2%
1,027,046
+250.5%
0.12%
+110.9%
Q1 2020$457,000
-84.5%
292,999
-64.8%
0.06%
-56.0%
Q1 2018$2,947,000
-24.6%
832,500
-17.3%
0.12%
-39.0%
Q4 2017$3,907,000
+64.5%
1,006,900
+7.7%
0.20%
+70.8%
Q3 2017$2,375,000
+45.4%
935,000
+56.4%
0.12%
+36.4%
Q2 2017$1,633,000
-0.1%
598,000
+21.1%
0.09%
+8.6%
Q1 2017$1,635,000
-12.0%
494,000
-36.7%
0.08%
-34.1%
Q4 2016$1,859,000
-32.6%
781,000
+3.9%
0.12%
-21.2%
Q3 2016$2,759,000
+69.7%
751,629
+3.1%
0.16%
+83.5%
Q2 2016$1,626,000
+88.9%
729,200
+76.2%
0.08%
+60.4%
Q1 2016$861,000413,7890.05%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders